Get startedLog in
    Picture of Viracta Therapeutics logo

    VIRX — Viracta Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Viracta Therapeutics Reports Q4 And Full Year 2021 Financial Results

    Picture of Viracta Therapeutics logoViracta Therapeutics
    16/03/2022 12:31
    March 16 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS  AND PROVIDES A CORPORATE UPDATE
    * Q4 LOSS PER SHARE $0.31
    * CASH BALANCE OF $103.6 MILLION AS OF DECEMBER 31, 2021,
EXPECTED
TO BE SUFFICIENT TO FUND OPERATIONS INTO MID-2024

Source text for Eikon:  ID:nPnbKhgYja 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Viracta Therapeutics

    See all news